OL
Insider
Orbimed Advisors Llc
DirectorOrbimed Advisors Llc (Director) filed 15 Form 4 reports as a reporting entity in the trailing twelve months (7 purchases, 8 sales, 1 filed past the two-business-day deadline), most often in Sionna Therapeutics, Inc. (SION). Across 7 priced purchase filings, the average 21-session return was +16.9% from execution and +18.9% from disclosure (delay-adjusted; derived). The largest single filing was $38.9M of ELVN (858,646 sh across 3 lots, as filed), executed Jun 22.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+16.9%
avg across 7 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+18.9%
same 7 filings, from disclosure
Filings, ttm
15
7 buys · 8 sells · 1 late
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$197.7M
shares × price, as filed
Last traded
Aug 10
Filed Aug 12
Median ADV $10.0M across their filed names
Impact on $10,000 · 12M
$16,673 (+66.7%)
S&P 500 $11,725 (+17.2%) · 49.5 pts ahead
Orbimed Advisors Llc
S&P 500
Compounded across filings from disclosure dates · past 12 months
Open performance→Volume by month
Buys $112.9M
Sells $113.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
12 filings
Not on file
3 filings
Sector per market data · by filing · past 12 months
Most traded names
SIONRecent filings
STTKPURCHASE
Shattuck Labs, Inc.
View filing →
$5.5M6,306,127 sh across 2 lots
Exec Aug 25 2025
Filed Sep 2 2025 · 9:52 PM ET † CRVSSALE Corvus Pharmaceuticals, Inc. View filing → $4.9M
1,176,332 sh × $4.16
Exec Jun 27 2025
Filed Jul 1 2025 · 5:30 PM ET NPCESALE NeuroPace Inc View filing → $2.7M
168,136 sh across 2 lots
Exec May 14 2025
Filed May 16 2025 · 5:30 PM ET IRONSALE Disc Medicine, Inc. View filing → $270K
4,982 sh across 2 lots
Exec Mar 24 2025
Filed Mar 26 2025 · 5:30 PM ET UPBPURCHASE Upstream Bio, Inc. View filing → $14.0M
825,000 sh across 2 lots
Exec Oct 15 2024
Filed Oct 17 2024 · 5:30 PM ET MBXPURCHASE MBX Biosciences, Inc. View filing → $12.0M
750,000 sh across 2 lots
Exec Sep 16 2024
Filed Sep 17 2024 · 5:30 PM ET